Literature DB >> 2070698

Fasting gastric pH and its relationship to true hypochlorhydria in humans.

M Feldman1, C Barnett.   

Abstract

Abnormally low rates of gastric acid secretion (hypochlorhydria) are associated with bacterial overgrowth, enteric infection, and with hypergastrinemia and an increased risk of gastric neoplasms. In the present study, we evaluated the ability of fasting gastric juice pH measurements to detect true hypochlorhydria. True hypochlorhydria was defined as a peak acid output in response to a maximally effective stimulant of acid secretion that was below the lower limit of normal for 365 consecutive healthy subjects. In these healthy subjects, average basal pH was 2.16 +/- 0.09 in men and 2.79 +/- 0.18 in women. In 109 consecutive experiments in 28 subjects with true hypochlorhydria, fasting gastric pH averaged 7.44 +/- 0.11 in men and 7.65 +/- 0.33 in women. Fasting pH exceeded the upper 95% confidence limit of normal (5.09 in men and 6.81 in women) in 102 of the 109 experiments (94%). Thus, fasting pH measurement was a sensitive method for diagnosing bona fide hypochlorhydria.

Entities:  

Mesh:

Year:  1991        PMID: 2070698     DOI: 10.1007/BF01297133

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  BASAL AND HISTALOG-STIMULATED GASTRIC SECRETION IN CONTROL SUBJECTS AND IN PATIENTS WITH PEPTIC ULCER OR GASTRIC CANCER.

Authors:  M I GROSSMAN; J B KIRSNER; I E GILLESPIE
Journal:  Gastroenterology       Date:  1963-07       Impact factor: 22.682

2.  The augmented histamine test with special reference to achlorhydria.

Authors:  S T CALLENDER; F P RETIEF; L J WITTS
Journal:  Gut       Date:  1960-12       Impact factor: 23.059

3.  THE DETERMINATION OF GASTRIC ACIDITY BY THE GLASS ELECTRODE.

Authors:  E W MOORE; R W SCARLATA
Journal:  Gastroenterology       Date:  1965-08       Impact factor: 22.682

4.  Some fallacies in the clinical measurement of gastric acidity with special reference to the histamine test.

Authors:  H SHAY; A KOMAROV; J E BERK
Journal:  Gastroenterology       Date:  1950-05       Impact factor: 22.682

Review 5.  Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective.

Authors:  R A Giannella; S A Broitman; N Zamcheck
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

6.  Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; H Mattsson; L Lundell; F Sundler; G Sundell; B Wallmark; T Watanabe; R Håkanson
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

7.  Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway.

Authors:  G C du Moulin; D G Paterson; J Hedley-Whyte; A Lisbon
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

8.  Toxicological studies on omeprazole.

Authors:  L Ekman; E Hansson; N Havu; E Carlsson; C Lundberg
Journal:  Scand J Gastroenterol Suppl       Date:  1985

9.  The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy.

Authors:  J A Carney; V L Go; V F Fairbanks; S B Moore; E C Alport; F E Nora
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

10.  Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients.

Authors:  M Feldman; C T Richardson; S K Lam; I M Samloff
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  11 in total

Review 1.  Meal-Time Supplementation with Betaine HCl for Functional Hypochlorhydria: What is the Evidence?

Authors:  Thomas G Guilliams; Lindsey E Drake
Journal:  Integr Med (Encinitas)       Date:  2020-02

2.  Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.

Authors:  T Skoczylas; I Sarosiek; S Sostarich; C McElhinney; S Durham; J Sarosiek
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

Review 3.  Population-based mechanistic prediction of oral drug absorption.

Authors:  Masoud Jamei; David Turner; Jiansong Yang; Sibylle Neuhoff; Sebastian Polak; Amin Rostami-Hodjegan; Geoffrey Tucker
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

4.  Small intestinal bacterial overgrowth in patients with rheumatoid arthritis.

Authors:  A E Henriksson; L Blomquist; C E Nord; T Midtvedt; A Uribe
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

5.  Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.

Authors:  Lori A Fischbach; Pelayo Correa; Mark Feldman; Elizabeth Fontham; Elisa Priest; Karen J Goodman; Rajeev Jain
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

6.  Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people.

Authors:  E Husebye; V Skar; T Høverstad; K Melby
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

7.  Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.

Authors:  Thanh Bach; Shirley Galbiati; Jessie K Kennedy; Gregory Deye; Effie Y H Nomicos; Ellen E Codd; Hector H Garcia; John Horton; Robert H Gilman; Armando E Gonzalez; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 8.  The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs.

Authors:  Shanna C Trenaman; Susan K Bowles; Melissa K Andrew; Kerry Goralski
Journal:  Pharmacol Res Perspect       Date:  2021-05

9.  Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice.

Authors:  Andrew Goodyear; Helle Bielefeldt-Ohmann; Herbert Schweizer; Steven Dow
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

10.  Do proton pump inhibitors decrease calcium absorption?

Authors:  Karen E Hansen; Andrea N Jones; Mary J Lindstrom; Lisa A Davis; Toni E Ziegler; Kristina L Penniston; Amy L Alvig; Martin M Shafer
Journal:  J Bone Miner Res       Date:  2010-06-24       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.